Carnero A - Search Results

1

The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. Carnero A, et al. Curr Cancer Drug Targets. 2008 May;8(3):187-98. doi: 10.2174/156800908784293659. Curr Cancer Drug Targets. 2008. PMID: 18473732 Review.

2

Targeting the cell cycle for cancer therapy.

Carnero A. Carnero A. Br J Cancer. 2002 Jul 15;87(2):129-33. doi: 10.1038/sj.bjc.6600458. Br J Cancer. 2002. PMID: 12107831 Free PMC article. Review.

3

Overexpression of cyclin D1 inhibits TNF-induced growth arrest.

Moneo V, del Valle Guijarro M, Link W, Carnero A. Moneo V, et al. Among authors: carnero a. J Cell Biochem. 2003 Jun 1;89(3):484-99. doi: 10.1002/jcb.10529. J Cell Biochem. 2003. PMID: 12761882

4

Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt.

Link W, Rosado A, Fominaya J, Thomas JE, Carnero A. Link W, et al. Among authors: carnero a. J Cell Biochem. 2005 Aug 1;95(5):979-89. doi: 10.1002/jcb.20479. J Cell Biochem. 2005. PMID: 15838873

5

Identification of transcripts specific for physiological gene activation by platelet-derived growth factor (PDGF)-B in intact brain tissue.

Renner O, Romero L, Carnero A, Betsholtz C, Euler M. Renner O, et al. Among authors: carnero a. J Cell Biochem. 2005 Jul 1;95(4):859-67. doi: 10.1002/jcb.20478. J Cell Biochem. 2005. PMID: 15838875

6

Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.

Sotillo R, Renner O, Dubus P, Ruiz-Cabello J, Martín-Caballero J, Barbacid M, Carnero A, Malumbres M. Sotillo R, et al. Among authors: carnero a. Cancer Res. 2005 May 1;65(9):3846-52. doi: 10.1158/0008-5472.CAN-04-4195. Cancer Res. 2005. PMID: 15867383

7

Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria.

Blanco-Aparicio C, Pequeño B, Moneo V, Romero L, Leal JF, Velasco J, Fominaya J, Carnero A. Blanco-Aparicio C, et al. Among authors: carnero a. Anticancer Drugs. 2005 Oct;16(9):977-87. doi: 10.1097/01.cad.0000180117.93535.cf. Anticancer Drugs. 2005. PMID: 16162974

8

Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53.

Moneo V, Serelde BG, Fominaya J, Leal JF, Blanco-Aparicio C, Romero L, Sánchez-Beato M, Cigudosa JC, Tercero JC, Piris MA, Jimeno J, Carnero A. Moneo V, et al. Among authors: carnero a. J Cell Biochem. 2007 Feb 1;100(2):339-48. doi: 10.1002/jcb.21073. J Cell Biochem. 2007. PMID: 16888811

9

Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.

Blanco-Aparicio C, Pérez-Gallego L, Pequeño B, Leal JF, Renner O, Carnero A. Blanco-Aparicio C, et al. Among authors: carnero a. Carcinogenesis. 2007 Mar;28(3):584-94. doi: 10.1093/carcin/bgl190. Epub 2006 Oct 17. Carcinogenesis. 2007. PMID: 17050554

10

PTEN, more than the AKT pathway.

Blanco-Aparicio C, Renner O, Leal JF, Carnero A. Blanco-Aparicio C, et al. Among authors: carnero a. Carcinogenesis. 2007 Jul;28(7):1379-86. doi: 10.1093/carcin/bgm052. Epub 2007 Mar 6. Carcinogenesis. 2007. PMID: 17341655 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters